Brinzolamide OverviewBrinzolamide (trade names Azopt, Alcon Laboratories, Befardin, Fardi Medicals, ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication in the United States in November 2020. Contents 1 Chemistry 2 Indications 3 Pharmacodynamics 4 Pharmacokinetics 4.1 Absorption 4.2 Distribution 4.3 Metabolism 4.4 Excretion 5...
Read more Brinzolamide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brinzolamide
Recent Brinzolamide Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Suspension: 1%
- Suspension/drops: 1%
NDC Database Records for Brinzolamide: (4 results)Sorted by National Drug Code
- 0591-2127 Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops by Actavis Pharma, Inc.
- 0781-6014 Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops by Sandoz Inc
- 63629-8793 Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops by Bryant Ranch Prepack
- 68682-464 Brinzolamide 10 mg/ml Ophthalmic Suspension/ Drops by Oceanside Pharmaceuticals.
Other drugs which contain Brinzolamide or a similar ingredient: (3 results)
- AZOPT Brinzolamide1 discussion
- BRINZOLAMIDE + BRIMONIDINE TARTRATE
- SIMBRINZA Brinzolamide + Brimonidine Tartrate2 discussions